Blockmate Ventures Inc
XTSX:MATE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Blockmate Ventures Inc
XTSX:MATE
|
UK |
|
P
|
Phong Phu Pharmaceutical JSC
VN:PPP
|
VN |
|
B
|
Brickell Biotech Inc
F:VCC2
|
US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
US |
|
Aurora Labs Ltd
ASX:A3D
|
AU |
|
Shandong Longquan Pipeline Engineering Co Ltd
SZSE:002671
|
CN |
|
PostNL NV
AEX:PNL
|
NL |
|
E
|
Ever Glory United Holdings Ltd
SGX:ZKX
|
SG |
|
Fintech Scion Ltd
OTC:FINR
|
UK |
|
Jiangsu Transimage Technology Co Ltd
SZSE:002866
|
CN |
|
L
|
LithiumBank Resources Corp
XTSX:LBNK
|
CA |
|
Soder Sportfiske AB
F:98Q
|
SE |
|
P
|
Poh Huat Resources Holdings Bhd
KLSE:POHUAT
|
MY |
|
M
|
MDC Holdings Inc
LSE:0JW5
|
US |
|
Olav Thon Eiendomsselskap ASA
OSE:OLT
|
NO |
|
D Market Elektronik Hizmetler ve Ticaret AS
NASDAQ:HEPS
|
TR |
|
S
|
Suryoday Small Finance Bank Ltd
NSE:SURYODAY
|
IN |
|
Roivant Sciences Ltd
F:87S
|
UK |
|
Hanchang Corp
KRX:005110
|
KR |
|
B
|
Bank of Zhengzhou Co Ltd
SZSE:002936
|
CN |
Cash Flow Statement
Cash Flow Statement
Blockmate Ventures Inc
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||
| Net Income |
(1)
|
(4)
|
(4)
|
(5)
|
(5)
|
(3)
|
(2)
|
(3)
|
(2)
|
(2)
|
(4)
|
(3)
|
(5)
|
(7)
|
(7)
|
(7)
|
(6)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
0
|
0
|
2
|
0
|
3
|
3
|
(0)
|
1
|
0
|
(0)
|
0
|
(1)
|
0
|
0
|
4
|
4
|
4
|
|
| Change in Working Capital |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(0)
|
(0)
|
1
|
1
|
0
|
0
|
(0)
|
|
| Cash from Operating Activities |
(1)
N/A
|
(3)
-137%
|
(2)
+46%
|
(2)
-10%
|
(2)
-7%
|
(0)
+100%
|
(2)
-46 653%
|
(2)
-3%
|
(2)
-22%
|
(3)
-23%
|
(3)
-22%
|
(4)
-16%
|
(4)
-12%
|
(6)
-33%
|
(3)
+51%
|
(2)
+13%
|
(2)
+35%
|
|
| Investing Cash Flow | ||||||||||||||||||
| Capital Expenditures |
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
2
|
2
|
1
|
(0)
|
(1)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(1)
-422%
|
(0)
+20%
|
(0)
+5%
|
(0)
+5%
|
0
N/A
|
(0)
N/A
|
(0)
+11%
|
(0)
+26%
|
(0)
-31%
|
(0)
+31%
|
1
N/A
|
2
+76%
|
2
+46%
|
1
-67%
|
(0)
N/A
|
(1)
-94%
|
|
| Financing Cash Flow | ||||||||||||||||||
| Net Issuance of Common Stock |
3
|
2
|
(0)
|
0
|
3
|
1
|
2
|
2
|
1
|
1
|
0
|
0
|
2
|
3
|
3
|
3
|
1
|
|
| Net Issuance of Debt |
(0)
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
(1)
|
1
|
3
|
2
|
3
|
1
|
0
|
1
|
1
|
0
|
|
| Other |
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
0
|
(1)
|
0
|
0
|
1
|
1
|
(1)
|
(1)
|
(1)
|
|
| Cash from Financing Activities |
3
N/A
|
2
-27%
|
(0)
N/A
|
0
N/A
|
1
+1 592%
|
(1)
N/A
|
2
N/A
|
2
-3%
|
2
+20%
|
3
+21%
|
3
-8%
|
3
+3%
|
4
+50%
|
4
+6%
|
3
-38%
|
3
-3%
|
1
-78%
|
|
| Change in Cash | ||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
2
N/A
|
(2)
N/A
|
(2)
-48%
|
(2)
-3%
|
(2)
+23%
|
(1)
+16%
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
-58%
|
(1)
N/A
|
(0)
+68%
|
1
N/A
|
1
-33%
|
1
-6%
|
(0)
N/A
|
(2)
-43 640%
|
|
| Free Cash Flow | ||||||||||||||||||
| Free Cash Flow |
(1)
N/A
|
(4)
-157%
|
(2)
+43%
|
(2)
-9%
|
(2)
-5%
|
0
N/A
|
(2)
N/A
|
(2)
-3%
|
(2)
-21%
|
(3)
-23%
|
(3)
-22%
|
(4)
-16%
|
(4)
-12%
|
(6)
-33%
|
(3)
+51%
|
(2)
+13%
|
(2)
+35%
|
|